Article Text

Download PDFPDF

The association between tobacco and the risk of asthma, rhinoconjunctivitis and eczema in children and adolescents: analyses from Phase Three of the ISAAC programme
  1. Edwin A Mitchell1,
  2. Richard Beasley2,
  3. Ulrich Keil3,
  4. Stephen Montefort4,
  5. Joseph Odhiambo5,
  6. and the ISAAC Phase Three Study Group*
  1. 1Department of Paediatrics: Child and Youth Health, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
  2. 2Medical Research Institute of New Zealand, Wellington, New Zealand
  3. 3Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany
  4. 4Department of Medicine, University of Malta, Malta
  5. 5Centre Respiratory Diseases Research Unit, Kenya Medical Research Institute, Nairobi, Kenya
  1. Correspondence to Professor Edwin A Mitchell, Department of Paediatrics: Child and Youth Health, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland, New Zealand; e.mitchell{at}auckland.ac.nz

Footnotes

  • * ISAAC Phase Three Study Group are listed in appendix 1.

  • Funding Currently the main source of funding for the ISAAC International Data Centre (IIDC) is The New Zealand Lotteries Grant Board. Many New Zealand funding bodies have contributed support for the IIDC during the periods of fieldwork and data compilation (the Health Research Council of New Zealand, the Asthma and Respiratory Foundation of New Zealand, the Child Health Research Foundation, the Hawke's Bay Medical Research Foundation, the Waikato Medical Research Foundation, The Auckland Medical Research Foundation, Glaxo Wellcome New Zealand and Astra Zeneca New Zealand). Glaxo Wellcome International Medical Affairs and The BUPA Foundation supported the regional coordination for Phase Three and the IIDC. Without help from all of the above, ISAAC would not have been such a global success. EA Mitchell is supported by Cure Kids (NZ).

  • Competing interests None.

  • Ethics approval Each participating centres obtained approval according to their laws and regulations.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement At this moment in time the data are confidential to each centre and the ISAAC International Data Centre.

View Full Text

Statistics from Altmetric.com

Supplementary materials

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Footnotes

  • * ISAAC Phase Three Study Group are listed in appendix 1.

  • Funding Currently the main source of funding for the ISAAC International Data Centre (IIDC) is The New Zealand Lotteries Grant Board. Many New Zealand funding bodies have contributed support for the IIDC during the periods of fieldwork and data compilation (the Health Research Council of New Zealand, the Asthma and Respiratory Foundation of New Zealand, the Child Health Research Foundation, the Hawke's Bay Medical Research Foundation, the Waikato Medical Research Foundation, The Auckland Medical Research Foundation, Glaxo Wellcome New Zealand and Astra Zeneca New Zealand). Glaxo Wellcome International Medical Affairs and The BUPA Foundation supported the regional coordination for Phase Three and the IIDC. Without help from all of the above, ISAAC would not have been such a global success. EA Mitchell is supported by Cure Kids (NZ).

  • Competing interests None.

  • Ethics approval Each participating centres obtained approval according to their laws and regulations.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement At this moment in time the data are confidential to each centre and the ISAAC International Data Centre.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.